TherapeuticsMD
TXMD
TXMD
138 hedge funds and large institutions have $1.18B invested in TherapeuticsMD in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 48 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
-8
Holders Change %
-5.48%
% of All Funds
3.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
16
Increased
49
Reduced
48
Closed
15
Calls
$3.38M
Puts
$1.69M
Net Calls
+$1.69M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
BlackRock
New York
|
+$79.1M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$15.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.7M |
| 4 |
NM
Newtyn Management
New York
|
+$9.72M |
| 5 |
CCI
Columbus Circle Investors
|
+$9.39M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$33.4M |
| 2 |
Millennium Management
New York
|
-$12.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$6.16M |
| 4 |
Bank of New York Mellon
New York
|
-$5.73M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$3.9M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AP
151
Atwood & Palmer
Kansas City,
Missouri
| – | -$43K | -150 | Closed |
|
152
Bessemer Group
Woodbridge,
New Jersey
| – | -$2K | -8 | Closed |
|